TBX22
protein-codingT-box transcription factor 22, the group of T-box transcription factors
Gene summary
This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. Mutations in this gene have been associated with the inherited X-linked disorder, Cleft palate with ankyloglossia, and it is believed to play a major role in human palatogenesis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
- CPX
- CLPA
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010560
Submitter: ClinGen
TBX22 was first reported in relation to X-linked cleft palate with/without ankyloglossia in 2001 (Braybrook et al., PMID: 11559848 ). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, or phenotypic variability. Therefore, the following disease entities have been lumped into one disease entity, Abruzzo-Erikson syndrome (OMIM:302905) and cleft palate with ankyloglossia (OMIM:303400). 9 variants (missense, nonsense, frameshift, splicing) that have been reported in over 30 probands in 5 publications (PMIDs: 11559848, 14729838, 22784330, 29932061, 30462376) are included in this curation. The phenotypes of some of the affected families were reported in earlier publications (PMIDs: 839509, 1570839), before TBX22 was discovered as the causative gene. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (mouse model, expression-level evidence; PMIDs: 19648291, 20845426). The mouse model shows that mutant mice exhibit ankyloglossia and submucous cleft palate. Expression-level data in mice embryos show expression of the gene in the palatal bone. In summary, there is definitive evidence supporting the relationship between TBX22 and X-linked cleft palate with/without ankyloglossia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations GCEP on the meeting date 9/19/2024 (SOP Version 11).
Inheritance Pattern: XL
Disease ID:MONDO:0010560
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010560
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010554
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010560
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010554
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010560
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Genitourinary; Musculoskeletal; Ophthalmologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TBX22 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001109878.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 17 | 3 | 28 | ||
| missense | 3 | 7 | 88 | 4 | 1 | 103 |
| nonsense | 2 | 2 | 4 | |||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 1 | 3 | |||
| splice donor/acceptor (+/-2bp) | 2 | 2 | 4 | 8 | ||
| Total | 7 | 12 | 103 | 21 | 4 | 147 |
Highest pathogenic variant AF is 0.0000074480868
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001103348.1 | 8 | MANE Select | |
| Ensembl | ENSP00000362393.3 | 8 | MANE Select | |
| RefSeq | NP_001103349.1 | 6 | Standard | |
| RefSeq | NP_001290404.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- negative regulation of transcription by RNA polymerase II
- regulation of transcription, DNA-templated
- multicellular organism development
- negative regulation of transcription, DNA-templated
Molecular Function
- RNA polymerase II regulatory region sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- DNA binding
- DNA-binding transcription factor activity
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000373294
- Coding exons
- 8
- Length
- 17014
- Individuals with no LoFs
- 125646
- Homozygous LoFs
- 3
- Heterozygous LoFs
- 6
- Defined
- 125655
- p
- 0.0000358
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.126 | 204 | 199 | 1.03 | 0.0000145 | 3425 |
| Missense (PolyPhen) | 55 | 65.412 | 0.84083 | 1072 | ||
| Synonymous | -0.266 | 80 | 77.0 | 1.04 | 0.00000611 | 997 |
| Loss of Function | 3.47 | 1 | 16.0 | 0.0625 | 0.00000117 | 277 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000076 | 0.000062 | rare |
| Latino/Admixed American | 0.00022 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000072 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000012 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probable transcriptional regulator involved in developmental processes. This is major determinant crucial to palatogenesis.;
- Disease
- DISEASE: Abruzzo-Erickson syndrome (ABERS) [MIM:302905]: A disease characterized by cleft palate, coloboma, hypospadias, deafness, short stature, and radial synostosis. {ECO:0000269|PubMed:22784330}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.128
Intolerance Scores
- LoFtool
- 0.0586
- RVIS EVS
- -0.18
- RVIS percentile EVS
- 40.16
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.610
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |